study design
Follow-up Schedule
Parameters | Detailed information | Screening | Baseline | 1 Y | 2 Y | 3 Y | 4 Y | 5 Y | Improvement or deterioration of clinical outcomes |
Hard outcomes (ESRD, CV outcomes) |
---|---|---|---|---|---|---|---|---|---|---|
Informed consent | O | |||||||||
Demo graphic | O | |||||||||
information | O | |||||||||
Medical history | ||||||||||
Medications | Hypertensive medications | O | O | O | O | O | O | O | O | |
Immunosuppressant | O | O | O | O | O | O | O | O | ||
Questionn aires | Health questionnaires (including smoking) | O | O | O | O | O | O | O | O | |
KDQOL-SF version 1.3 questionnaires | O | O | O | O | O | O | O | O | ||
Semi-food frequency questionnaires | O | O | O | O | O | O | O | O | ||
PedsQL 4.0 Generic Core Scales (Children) | O | O | ||||||||
Blood laboratory findings | CBC (white blood cell count, platelet, haemoglobin) | O | O | O | O | O | O | O | O | |
Chemistry (calcium, phosphorus, glucose, blood urea nitrogen, uric acid, total protein, albumin, total bilirubin, alkaline phosphatase, AST, ALT) | O | O | O | O | O | O | O | O | ||
IDMS-traceable Cr, eGFR | O | O | O | O | O | O | O | O | ||
Lipid panel (total cholesterol, triglyceride, high-density lipoprotein, low density lipoprotein) | O | O | O | O | O | O | O | O | ||
Electrolyte panel (sodium, potassium, chloride) | O | O | O | O | O | O | O | O | ||
Total CO2 | O | O | O | O | O | O | O | O | ||
C-reactive protein | O | O | O | O | O | O | O | O | ||
Serology (HBsAg, HBsAb, Anti-HCV, HIV, VDRL) | O | |||||||||
Anti-dsDNA, FANA, FANA titre, ANCA, PR3, MPO | O | |||||||||
Complement 3, 4 | O | |||||||||
ASO, rheumatoid factor, Cryoglobulin | O | |||||||||
Urine laboratory findings | Random urine protein | O | O | O | O | O | O | O | O | |
Random urine microalbumin | O | O | O | O | O | O | O | O | ||
Random urine creatinine | O | O | O | O | O | O | O | O | ||
Urinalysis protein | O | O | O | O | O | O | O | O | ||
Urinalysis RBC | O | O | O | O | O | O | O | O | ||
Kidney biopsy | Biopsy results and images including LM, IF and EM | O | ||||||||
Report of diagnosis | O | |||||||||
Total number of glomeruli | O | |||||||||
Total number of global sclerosis/segmental sclerosis/crescent | O |